Novel Therapies Prostate-Specific Antigen (PsA) and Spondyloarthropathy (SpA)

Novel Therapies Prostate-Specific Antigen (PsA) and Spondyloarthropathy (SpA) is organized by Cleveland Clinic Foundation Center for Continuing Education and would be held during May 10, 2017 - May 10, 2019.

The target audience for this medical event for rheumatologists, dermatologists, allergists, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.

This CME Conference has been approved with a maximum of 0.75 AMA PRA Category 1 Credit. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Conference Objectives are:
• Describe new concepts in the diagnosis and treatment of psoriatic arthritis and ankylosing spondylitis.
• Review new treatment recommendations for PsA and SpA.
• Discuss novel and emerging therapies for PsA and SpA

Additional details will be posted as soon as they are available.